Aplos Medical is developing Omega PF, a partial surround (partial fundoplication) device designed to prevent excess stomach acid from entering the esophagus while allowing much of the normal swallowing physiology to remain intact. The company has also designed it to minimize dysphagia and side effects common to other GERD treatments.
A surgeon can laparoscopically implant the omega-shaped, nitinol device in an hour-long procedure, according to the company’s website. Omega PF was also designed to lead to fewer postoperative problems than other devices made for the same purpose. Aplos Medical partially credits Dr. Robert Ganz, the 2017 recipient of the Americal Society of Gastrointestinal Endoscopy’s highest honor, with providing valuable input as it moves toward clinical testing of the device.